EP. 1: Peer Exchange: The Importance of Improving DE&I in Clinical Trials
In the first part of this roundtable discussion, a panel of experts introduce themselves and highlight the challenges industry is seeing with underrepresentation of racial and ethnic groups in clinical trials.
EP. 2: Peer Exchange: Reaching Underrepresented Patient Populations
In the second part of this roundtable discussion, participants highlight best practices for reaching underrepresented populations and increasing their awareness of clinical trials.
EP. 3: Peer Exchange: Accountability for Implementing Diversity Action Plans
Participants touch on the different aspects of FDA's recent Diversity Action Plan guidance and how industry must be held accountable for implementing change.
EP. 4: Peer Exchange: Technology's Role in Achieving Greater DE&I in Clinical Trials
Industry experts discuss the use of decentralized technologies and the potential of artificial intelligence in reaching underrepresented patient populations.
EP. 5: Peer Exchange: Technology Accessibility
In the fifth and final part of this roundtable discussion, participants discuss the practice of designing technology with patients in mind and share their concluding thoughts on improving diversity in clinical trials.